Clinical Studies on HIFU for Varicose Vein Treatment: A Comprehensive Review
**Disclaimer:** This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
Introduction
Varicose veins, a common vascular disorder affecting a significant portion of the global population, are characterized by dilated, tortuous superficial veins resulting from chronic venous insufficiency. This condition can lead to various symptoms, including leg pain, swelling, skin changes, and in severe cases, venous ulcers. Traditional treatments, while effective, often involve invasive procedures with associated complications and prolonged recovery times. High-Intensity Focused Ultrasound (HIFU) has emerged as a promising non-invasive alternative, offering precise targeting of affected veins without skin penetration [1]. This review synthesizes findings from recent clinical studies to provide a comprehensive overview of HIFU's mechanism of action, clinical applications, efficacy, safety, advantages, and limitations in the treatment of varicose veins.
Mechanism of Action of HIFU
HIFU technology utilizes focused ultrasonic waves to generate both thermal and mechanical effects at specific tissue depths. The focused energy rapidly elevates the temperature at the focal point to approximately 85°C–90°C, inducing coagulative necrosis and subsequent fibrosis of the target vein. This process leads to immediate vein wall shrinkage and occlusion, while carefully sparing surrounding healthy tissues [1].
The HIFU system integrates diagnostic ultrasound imaging for real-time guidance, allowing for accurate localization of the target vein and continuous monitoring of the treatment area. Therapeutic transducers deliver the energy, with advanced algorithms adjusting parameters such as frequency, energy density, and pulse duration based on individual patient anatomy and vein characteristics. Cooling mechanisms are incorporated to protect the skin surface, enhancing patient comfort and safety during the procedure [1]. Higher frequencies (up to 7.5 MHz) enable precise targeting of superficial veins, while optimized energy density ensures effective thermal effects without excessive tissue damage. Short pulses minimize collateral damage and allow for adequate cooling periods between emissions [1].
Clinical Applications
HIFU has demonstrated efficacy across several clinical applications in varicose vein management:
1. Treatment of Great Saphenous Vein (GSV) Incompetence
GSV reflux is a primary cause of varicose veins. Clinical trials have shown high occlusion rates for GSV incompetence, with studies reporting closure rates exceeding 95% at 12-month follow-ups [1]. Its non-invasive nature makes it a suitable option for patients who may not be candidates for traditional interventions due to comorbidities or anticoagulant therapy [1].
2. Management of Venous Ulcers
Refluxing perforator veins significantly contribute to venous ulceration. HIFU effectively targets these perforators, promoting ulcer healing. Case studies have highlighted its potential, such as complete healing of chronic ulcers within three months post-HIFU in a 95-year-old patient [1].
3. Patients with Compromised Skin Integrity and Anticoagulated Patients
For patients with skin conditions like lipodermatosclerosis or those on anticoagulation therapy, invasive procedures carry higher risks. HIFU offers a safe alternative by eliminating the need for skin penetration, thereby reducing infection risks and bleeding complications. This allows for treatment without discontinuing anticoagulant medication [1].
4. Treatment of Telangiectasia and Superficial Venous Lesions
While primarily studied for larger varicose veins, the precise targeting capabilities of HIFU suggest potential for treating smaller superficial venous lesions, such as telangiectasia (spider veins). Further research is ongoing to optimize treatment parameters for these smaller vessels [1].
Efficacy and Safety Profile
Recent clinical evidence supports the efficacy and safety of HIFU. A multicenter study in 2022 reported a GSV closure rate of 96% at 6 months, with significant improvements in symptom scores and quality of life [1]. Another study evaluating HIFU for small saphenous vein incompetence demonstrated a 94% closure rate at 12 months, comparable to endovenous thermal ablation (EVTA) techniques [1].
The safety profile of HIFU is favorable, with minor complications such as transient skin erythema and paraesthesia reported in less than 5% of cases. Crucially, no major complications like deep vein thrombosis or nerve injury have been reported in reviewed studies [1]. Patients often report lower pain scores compared to EVTA, attributed to the absence of tumescent anesthesia and invasive instruments [1]. Histological analyses post-treatment confirm effective thermal damage, showing vein wall thickening, collagen hyalinization, and endothelial denudation [1].
In a retrospective study involving 204 limbs in 183 patients, HIFU combined with the CHIVA (Cure Conservatrice et Hémodynamique de l’Insuffisance Veineuse en Ambulatoire) strategy achieved primary leak point occlusion rates of 95.5% and secondary closure rates of 95.7% at 24 months, with no major complications observed [2]. These results underscore HIFU's role as an effective and safe noninvasive alternative for chronic venous disease treatment, minimizing risks associated with thermal ablation such as skin burns and nerve damage [2].
Advantages and Limitations
Advantages
- **Non-invasive:** Eliminates risks associated with skin penetration, such as infection and nerve injury [1].
- **Minimal Anesthesia:** Procedure-related minimal anesthesia requirements enhance patient comfort [1].
- **Rapid Recovery:** Patients can resume normal activities immediately post-procedure [1].
- **Suitability for High-Risk Patients:** Safe for individuals with bleeding disorders, on anticoagulants, or with poor skin integrity [1].
- **Selective Treatment:** Advanced imaging allows for selective treatment of affected vein segments, preserving healthy veins [1].
Limitations
- **Longer Procedure Times:** Cooling periods between energy deliveries can extend treatment duration compared to EVTA [1].
- **High Equipment Costs:** High costs and the need for specialized training limit widespread adoption [1].
- **Efficiency for Extensive Segments:** May be less efficient for treating extensive vein segments compared to traditional methods [1].
- **Expertise Required:** Requires expertise in ultrasound imaging and HIFU technology for optimal outcomes [1].
- **Vein Size and Depth:** Generally more effective for superficial and medium-sized varicose veins; larger or deeper veins may require higher energy levels or multiple sessions [1].
Conclusion
HIFU represents a transformative modality in the management of varicose veins, offering a non-invasive, safe, and effective alternative to traditional treatments. Its ability to deliver effective therapy without skin penetration is particularly beneficial for patients who are poor candidates for invasive procedures. While challenges remain regarding cost-effectiveness and accessibility, ongoing clinical trials and technological advancements are poised to position HIFU as a standard treatment option, ultimately improving patient outcomes and quality of life [1].
References
1. Shin, C. S., & Kim, J. I. (2024). High-intensity focused ultrasound in the treatment of varicose veins: a comprehensive review. *Annals of Phlebology*, *22*(2), 57-60. [https://synapse.koreamed.org/articles/1516089891](https://synapse.koreamed.org/articles/1516089891) 2. Lamoca, L. M. I., Postigo, T. R., Escalona, S. M., Arranz, J. F. G., & Acosta, A. A. (2025). High-intensity-focused ultrasound treatment for the chronic venous disease based on the Cure Conservatrice et Hémodynamique de l’Insuffisance Veineuse en Ambulatoire (CHIVA) strategy. *Journal of Vascular Surgery: Venous and Lymphatic Disorders*. [https://pmc.ncbi.nlm.nih.gov/articles/PMC12018035/](https://pmc.ncbi.nlm.nih.gov/articles/PMC12018035/)